FDA Inspection 1089368 — Flex-Cell Precision, Inc

Flex-Cell Precision, Inc — FEI 3010120135

The FDA completed an inspection of Flex-Cell Precision, Inc on March 27, 2019 in Lancaster, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 27, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Compliance: Devices
Location
Lancaster, PA (United States)

Citations

IDCFRDescription
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
44721 CFR 820.40Lack of procedures, or not maintained
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements
54621 CFR 820.75(a)Lack of or inadequate process validation